title: Effects of opioidergic systems upon anxiolytic-like behaviors induced in cholestatic rats.
abstract: Cholestasis is associated with endotoxinemia and elevated serum levels of bile acids, cholesterol, bile salts and opioids. Opioid systems have been reported to modulate anxiety. In the present study, the possible involvement of opioidergic system on anxiolytic-like behaviors induced by cholestasis was investigated. Cholestasis was induced in male Wistar rats by ligation of the main bile duct using two ligatures and transecting the duct at the midpoint between them. A standard elevated plus-maze was used to determine anxiety levels in animals. The data indicated that there is an increase, 13 days (but not 10 days) after bile duct ligation, in the percentage of open arm time (%OAT) and open arm entries (%OAE) but not locomotor activity, grooming, rearing and defecation, showing anxiolytic-like effects of cholestasis. Intraperitoneal (i.p.) injection of a subthreshold dose of morphine (4 mg/kg), 15 min before testing 10 days after bile duct ligation, showed an increase in %OAT and %OAE, suggesting an anxiolytic-like effect for the drug. Furthermore, injection of subthreshold doses of naloxone (0.4 and 0.6 mg/kg, i.p.), 15 min before testing 13 days after bile duct ligation, decreased %OAT and %OAE. This indicates that naloxone blocks anxiolytic-like behaviors induced by cholestasis. Also, injection of a subthreshold dose of naloxone (0.4 mg/kg, i.p.), 15 min before the injection of a subthreshold dose of morphine (4 mg/kg, i.p.), 10 days after bile duct ligation, decreased %OAT and %OAE but not other behaviors. In conclusion, the results show the involvement of opioidergic system in anxiolytic-like behaviors induced by cholestasis.
authors.affiliation: Department of Biology, Faculty of Basic Sciences, Tarbiat Moalem University, Tehran, Iran.
authors.forename: Delaram
authors.initials: D
authors.lastname: Eslimi
authors.forename: Sharhbano
authors.initials: S
authors.lastname: Oryan
authors.forename: Mohammad
authors.initials: M
authors.lastname: Nasehi
authors.forename: Mohammad Reza
authors.initials: MR
authors.lastname: Zarrindast
mesh_terms: D000701:Analgesics, Opioid / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy* / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D001522:Behavior, Animal / Q000187:drug effects*; D001652:Bile Ducts / Q000601:surgery; D001835:Body Weight / Q000187:drug effects; D002779:Cholestasis / Q000150:complications*; D004305:Dose-Response Relationship, Drug; D005106:Exploratory Behavior / Q000187:drug effects; D008297:Male; D009020:Morphine / Q000494:pharmacology / Q000627:therapeutic use; D009270:Naloxone / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
chemical_list: D000701:Analgesics, Opioid; D014151:Anti-Anxiety Agents; D009270:Naloxone; D009020:Morphine